| Entry |
|
|---|
| Name |
Brimonidine tartrate (JAN/USAN);
Alphagan (TN) |
|---|
| Product |
|
|---|
| Generic |
BRIMONIDINE (Bryant Ranch Prepack), BRIMONIDINE (Padagis Israel Pharmaceuticals), BRIMONIDINE (Sandoz), BRIMONIDINE TARTRATE (A-S Medication Solutions), BRIMONIDINE TARTRATE (Alembic Pharmaceuticals Limited), BRIMONIDINE TARTRATE (Alembic Pharmaceuticals), BRIMONIDINE TARTRATE (Apotex Corp.), BRIMONIDINE TARTRATE (Apotex Corp.), BRIMONIDINE TARTRATE (Bausch & Lomb Incorporated), BRIMONIDINE TARTRATE (Florida Pharmaceutical Products), BRIMONIDINE TARTRATE (Indoco Remedies Limited), BRIMONIDINE TARTRATE (Pacific Pharma), BRIMONIDINE TARTRATE (Sandoz), BRIMONIDINE TARTRATE (Somerset Therapeutics), BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% (Alembic Pharmaceuticals Limited), BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% (Alembic Pharmaceuticals) |
|---|
| Formula |
C11H10BrN5. C4H6O6
|
|---|
| Exact mass |
441.0284
|
|---|
| Mol weight |
442.2214
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
|
|---|
| Remark |
| Therapeutic category: | 1319 |
| Product (DG00442): | D02076<JP/US> |
| Product (mixture): | D10298<JP/US> D10854<JP/US> D12437<JP> |
|
|---|
| Efficacy |
Antiglaucoma, alpha-Adrenergic receptor agonist |
|---|
| Disease |
Open-angle glaucoma [DS: H00612] |
|---|
| Comment |
Clonidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AX Other dermatologicals
D11AX21 Brimonidine
D02076 Brimonidine tartrate (JAN/USAN) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EA Sympathomimetics in glaucoma therapy
S01EA05 Brimonidine
D02076 Brimonidine tartrate (JAN/USAN) <JP/US>
S01G DECONGESTANTS AND ANTIALLERGICS
S01GA Sympathomimetics used as decongestants
S01GA07 Brimonidine
D02076 Brimonidine tartrate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Acne and Rosacea Agents
Acne and Rosacea Agents, Other
Brimonidine
D02076 Brimonidine tartrate (JAN/USAN)
Ophthalmic Agents
Intraocular Pressure Lowering Agents
Alpha-adrenergic Agonists, Ophthalmic
Brimonidine
D02076 Brimonidine tartrate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D02076 Brimonidine tartrate (JAN/USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG00442 Brimonidine
D02076 Brimonidine tartrate
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG00442 Brimonidine
D02076 Brimonidine tartrate
Drug classes [BR:br08332]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
D02076 Brimonidine tartrate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA2
D02076 Brimonidine tartrate (JAN/USAN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02076
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02076
Rx-to-OTC switch list in the USA [br08315.html]
D02076
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG00442 Brimonidine
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG00442 Brimonidine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 27
1 O6a O 21.8870 -16.5436
2 C6a C 23.0994 -15.8436
3 C1c C 24.3119 -16.5436
4 C1c C 25.5244 -15.8436
5 C6a C 26.7368 -16.5436
6 O6a O 27.9492 -15.8436
7 O6a O 23.1003 -14.4436
8 O6a O 26.7404 -17.9435
9 O1a O 24.3119 -17.9435
10 O1a O 25.5244 -14.4436
11 C8x C 9.7300 -16.3100
12 C8x C 9.7300 -17.7100
13 N5x N 10.9424 -18.4100
14 C8y C 12.1549 -17.7100
15 C8y C 12.1549 -16.3100
16 N5x N 10.9424 -15.6100
17 C8x C 13.3673 -18.4100
18 C8x C 14.5797 -17.7100
19 C8y C 14.5797 -16.3100
20 C8y C 13.3673 -15.6100
21 N2x N 17.0046 -17.7100
22 C2y C 17.0046 -16.3100
23 N1b N 15.7922 -15.6100
24 C1x C 18.3361 -18.1426
25 C1x C 19.1590 -17.0100
26 N1x N 18.3361 -15.8774
27 X Br 13.3673 -14.2100
BOND 28
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 2 7 2
7 5 8 2
8 3 9 1 #Up
9 4 10 1 #Up
10 11 12 2
11 12 13 1
12 13 14 2
13 14 15 1
14 15 16 2
15 11 16 1
16 14 17 1
17 17 18 2
18 18 19 1
19 19 20 2
20 15 20 1
21 21 22 2
22 22 23 1
23 19 23 1
24 21 24 1
25 24 25 1
26 25 26 1
27 22 26 1
28 20 27 1
|
|---|
